Cargando…
B cell depletion reduces the development of atherosclerosis in mice
B cell depletion significantly reduces the burden of several immune-mediated diseases. However, B cell activation has been until now associated with a protection against atherosclerosis, suggesting that B cell–depleting therapies would enhance cardiovascular risk. We unexpectedly show that mature B...
Autores principales: | Ait-Oufella, Hafid, Herbin, Olivier, Bouaziz, Jean-David, Binder, Christoph J., Uyttenhove, Catherine, Laurans, Ludivine, Taleb, Soraya, Van Vré, Emily, Esposito, Bruno, Vilar, José, Sirvent, Jérôme, Van Snick, Jacques, Tedgui, Alain, Tedder, Thomas F., Mallat, Ziad |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916123/ https://www.ncbi.nlm.nih.gov/pubmed/20603314 http://dx.doi.org/10.1084/jem.20100155 |
Ejemplares similares
-
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
por: Taleb, Soraya, et al.
Publicado: (2009) -
Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells
por: Ponnuswamy, Padmapriya, et al.
Publicado: (2017) -
Interleukin 5 Contributes to Human Atherosclerosis Development But not to Thrombotic Complications
por: Ait-Oufella, Hafid, et al.
Publicado: (2019) -
The Pathogenic Transforming Growth Factor-β Overdrive Hypothesis in Aortic Aneurysms and Dissections: A Mirage?
por: Mallat, Ziad, et al.
Publicado: (2017) -
Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis
por: Ait-Oufella, Hafid, et al.
Publicado: (2021)